Astro-Med (ALOT) Misses Q4 EPS by 4c
Tweet
Share
E-mailGet Alerts ALOT Hot Sheet
Price: $28.90 -0.07%
Financial Fact:
Research and Development: 1.76M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Research and Development: 1.76M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Astro-Med (NASDAQ: ALOT) reported Q4 EPS of $0.17, $0.04 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $23.8 million versus the consensus estimate of $25.5 million.
For earnings history and earnings-related data on Astro-Med (ALOT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
- Assembly Biosciences (ASMB) Tops Q2 EPS by 53c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
